Oral anticoagulant therapy for patients with atrial fibrillation on long‐term dialysis: A network meta‐analysis of 137,574 patients

Yao Du; Yan-Mei Zeng; Sixin Xu; Qiwei Shen; Jinzhu Hu; Professor Gregory Lip

doi:10.1111/eci.70120

Back

Oral anticoagulant therapy for patients with atrial fibrillation on long‐term dialysis: A network meta‐analysis of 137,574 patients

Article 2025 en

Abstract

1 min read

All OACs were not associated with a reduced risk of ischaemic stroke and/or systemic thromboembolism in patients with AF on long-term dialysis. Only apixaban 5 mg twice daily was associated with a decrease in all-cause mortality when compared with non-OAC use.

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Article2021

Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk

Tze‐Fan Chao, Professor Gregory Lip, S.A Chen

Article2016

Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project

Qinmei Xiong, Alena Shantsila, Juxiang Li, Kui Hong, Professor Gregory Lip

Article2021

Use of oral anticoagulation for people with atrial fibrillation post-stroke and associations with recurrent stroke and mortality: a systematic review

Mahum Shahid, Heshwin Singh, Deirdre A. Lane, Sunil Jit R. J. Logantha, Professor Gregory Lip, Stephanie L. Harrison

Article2020

Oral anticoagulants in extremely high risk very elderly (&gt;90 years) patients with Atrial Fibrillation

Tze‐Fan Chao, Professor Gregory Lip, S.A Chen

Article2021

Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk

Tze‐Fan Chao, Yi‐Hsin Chan, Chern‐En Chiang, Ta‐Chuan Tuan, Jo‐Nan Liao, Tzeng‐Ji Chen, Professor Gregory Lip, Shih‐Ann Chen

Oral anticoagulant therapy for patients with atrial fibrillation on long‐term dialysis: A network meta‐analysis of 137,574 patients

Abstract

Discussion(0)

Related publications

Stroke prevention with non-vitamin K antagonist oral anticoagulants in high risk elderly atrial fibrillation patients at increased bleeding risk

Suboptimal oral anticoagulant treatment among Chinese non-valvular atrial fibrillation patients: the Nanchang Atrial Fibrillation Project

Use of oral anticoagulation for people with atrial fibrillation post-stroke and associations with recurrent stroke and mortality: a systematic review

Oral anticoagulants in extremely high risk very elderly (&amp;gt;90 years) patients with Atrial Fibrillation

Stroke prevention with direct oral anticoagulants in high-risk elderly atrial fibrillation patients at increased bleeding risk

Oral anticoagulants in extremely high risk very elderly (>90 years) patients with Atrial Fibrillation